The influence of acetylsalicylic acid, phenylbutazone, indomethacin, and flufenamic acid on the kinetics of leucocytes during acute inflammation. 1980

C Caramanis, and D D Varonos

Five groups of ten male Wistar rats each were used for the purpose of this experiment. All subjects suffered from sterile acute inflammation in the peritoneal cavity. A sterile beef heart infusion broth reinforced with proteose-peptone was injected to cause the inflammation. The following substances mixed with tragacanth gum were given orally at in 12 h intervals: --Acetalsalicylic acid 150 mg/kg body weight to the first group; --Phenylbutazone 100 mg/kg body weight to the second group; --Indomethacin 15 mg/kg body weight to the third group; --Flufenamic acid 100 mg/kg body weight to the fourth group. Finally the fifth group received only tragacanth gum. The rats were sacrificed after 48 hours and leucocytes were collected from the peritoneal cavity by washing with 5 ml 0.9% NaCl solution. The total leucocyte number and the percent of each type were estimated for each group individually. A statistically significant decrease in the number of leucocytes migrated to the peritoneal cavity due to the inflammation was observed in rats that received one of the drugs (group I to IV) when compared to rats that received only the excipient (group V). Likewise, significant differences were noted in the composition of each type.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005439 Flufenamic Acid An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16) Dignodolin,Acid, Flufenamic
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

C Caramanis, and D D Varonos
January 2013, Eksperimental'naia i klinicheskaia farmakologiia,
C Caramanis, and D D Varonos
May 1970, Annals of physical medicine,
C Caramanis, and D D Varonos
January 1966, Annals of physical medicine,
C Caramanis, and D D Varonos
January 1966, Annals of physical medicine,
C Caramanis, and D D Varonos
June 1978, Vrachebnoe delo,
C Caramanis, and D D Varonos
January 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!